等待開盤 05-06 09:30:00 美东时间
-0.004
-0.45%
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从28美元升至49美元;HC Wainwright & Co.:维持Fate Therapeutics"买入"评级,目标价从5美元升至7美元
05-05 11:40
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Longeveron (NASDAQ:LGVN) with a Buy and lowers the price target from $10 to $8.
05-04 19:49
The latest announcement is out from Longeveron ( ($LGVN) ). In February 2026, L...
04-11 05:33
https://www.sec.gov/ix?doc=/Archives/edgar/data/1721484/000121390026042461/ea0285827-s1_longeveron.htm
04-11 04:10
Longeveron ( ($LGVN) ) has shared an update. On September 22, 2025, Longeveron ...
03-26 04:46
Longeveron ( ($LGVN) ) has issued an update. On March 23, 2026, Longeveron Inc....
03-25 04:38
Longeveron (NASDAQ:LGVN) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.32) by 30.6 percent. This is a 18.52 percent increase over losses of $(0.27) per share from the
03-18 04:08
Longeveron Inc. shares are trading higher Tuesday as investors pivot their focus toward the company's Q4 earnings report, due after the bell.
03-18 03:16
Companies Reporting Before The Bell • GDS Holdings (NASDAQ:GDS) is expected to ...
03-17 19:11
Agape ATP ($ATPC), Longeveron ($LGVN), and MiNK Therapeutics ($INKT) are the 3&...
03-11 22:11